Pregabalin Capsule 150 mg (Pregabalin)
Pregabalin 150mg
Hard capsule · Prescription medication
Sungwon Adcock Pharmaceutical Co., Ltd.
MFDS item code 201902107 · Approved 2019.04.05
This product's status changed to Expired on 2024.04.05. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of neuropathic pain; adjunctive treatment of partial seizures; treatment of fibromyalgia
This medication treats peripheral and central neuropathic pain in adults. It is also used as an adjunct in patients with epilepsy for partial seizures, showing effectiveness even in cases with secondary generalized symptoms. Additionally, it helps alleviate symptoms of fibromyalgia. In other words, it is used for various neurological-related disorders such as neuralgias, seizures, and fibromyalgia.
Administer the total daily dose of this drug as pregabalin orally in 2 divided doses, with or without food. Since this drug is primarily excreted by the kidneys, the dose should be adjusted in patients with impaired renal function (see section 5. Patients with Renal Impairment). 1. Neuropathic pain 1) Peripheral neuropathic pain Adults: This drug may be administered at an initial dose of 150 mg per day. Based on each patient's response and tolerability, the dose may be increased to 300 mg per day after 3 to 7 days. If needed, it may subsequently be increased at 7-day intervals up to a maximum of 600 mg per day. 2) Central neuropathic pain Adults: This drug may be administered at an initial dose of 150 mg per day. Based on each patient's response and tolerability, the dose may be increased to 300 mg per day after 1 week. After an additional week, it may be increased to the target daily dose of 600 mg. If the target daily dose is not tolerated, dose reduction may be considered (see section 4. Discontinuation). 2. Epilepsy Adults: This drug may be administered at an initial dose of 150 mg per day. Based on each patient's response and tolerability, the dose may be increased to 300 mg per day after 1 week. If needed, it may subsequently be increased at 7-day intervals up to a maximum of 600 mg per day. 3. Fibromyalgia The recommended dose of this drug for fibromyalgia is 300 mg-450 mg per day. The initial dose is 75 mg twice daily (150 mg per day), and based on efficacy and tolerability, may be increased within 1 week to 150 mg twice daily (300 mg per day). For patients who do not experience sufficient benefit at a dose of 300 mg per day, the dose may be increased within 1 week to 225 mg twice daily (450 mg per day). Clinical studies have also been conducted at a dose of 600 mg per day, but there is no evidence of additional benefit or adequate tolerability at this dose. In view of dose-dependent adverse reactions, doses exceeding 450 mg per day are not recommended. 4. Discontinuation Based on current clinical experience, if treatment with this drug is discontinued, it should be tapered gradually over an interval of at least 1 week. 5. Patients with renal impairment After entering the systemic circulation, this drug is excreted primarily by the kidneys unchanged. Since clearance of this drug is directly affected by creatinine clearance, dose reduction in patients with impaired renal function should be individualized based on creatinine clearance. Creatinine clearance [Table 1] is determined using the formula below. *For women, multiply the result obtained from the above calculation by 0.85. This drug is effectively removed from plasma by hemodialysis (approximately 50% within 4 hours). In patients undergoing hemodialysis, the daily dose of pregabalin should be adjusted based on renal function. In addition to the daily dose based on renal function, an additional supplemental dose should be administered promptly after every 4-hour hemodialysis session. [Table 1]. Pregabalin dosage based on renal function Creatinine clearance (CLcr), (mL/min) Total daily dose of pregabalina Administration method Starting dose (mg/day) Maximum dose (mg/day) ≥60 150 600 BID or TID ≥30-<60 75 300 BID or TID ≥15-<30 25-50 150 QD or BID <15 25 75 QD Supplemental dose after hemodialysis 25 100 Single dose b TID = divide the total daily dose into 3 doses BID = divide the total daily dose into 2 doses QD = administer once daily a: The total daily dose (mg/day) should be divided as specified under Administration method. b: An additional dose refers to a dose administered once as a supplement. 6. Patients with hepatic impairment No dose adjustment is required in patients with hepatic impairment. 8. Elderly patients (aged 65 years or older) Dose reduction may be necessary in elderly patients with impaired renal function.
There are insufficient safety and efficacy data for children under 12 years of age and adolescents aged 12-17 years; use is not recommended.
This medication may increase the risk of suicidal thoughts or behaviors, so it is essential to closely monitor for signs of depression, mood changes, or unusual behavior during treatment. There are contraindications for this medication: individuals allergic to this drug or its components or those with specific genetic conditions such as lactose intolerance should not take it. Diabetic patients may need to adjust their blood sugar control medications due to weight gain after taking this drug. If symptoms of allergic reactions, such as angioedema, appear, the medication should be discontinued immediately. Elderly patients should be cautious of the risk of falls or injuries due to dizziness or drowsiness when taking this medication, and they need to consult a physician if they experience blurred vision or changes in eyesight. Abruptly stopping this medication may cause withdrawal symptoms such as insomnia, headaches, nausea, and anxiety, so it should be tapered gradually according to a doctor's instructions. There is a risk of drug abuse or dependence, so patients with a history of mental illness should be monitored closely and checked for any signs of substance abuse. Patients with cardiovascular disease or kidney dysfunction should be cautious when taking this medication, and especially those with severe congestive heart failure should be administered carefully. Taking this medication with opioid pain relievers may increase central nervous system suppression, leading to a higher risk of respiratory depression, so caution is advised. In the early stages of pregnancy, there may be a risk of congenital malformations to the fetus, thus women who are pregnant or planning to become pregnant must consult their physician and employ effective contraceptive methods. Breastfeeding women should carefully consider the benefits and risks of taking this medication, as it may be transmitted through breast milk and affect the baby. It is safest to avoid activities requiring attention, such as driving or operating machinery, until dizziness or drowsiness fully resolves after taking this medication. In case of overdose, symptoms such as confusion, depression, drowsiness, and seizures may occur, and treatment such as hemodialysis may be required if necessary. This medication should be kept out of reach of children, and caution should be exercised as transferring it to a different container may alter its quality.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air or moisture, in a cool place between 15 to 30 degrees Celsius. Storing it this way will help maintain the medication's efficacy for a longer time.
A hard capsule with white powder inside, white in color.
30 capsules/bottle, 60 capsules/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Pregabalin 150mg
Hard capsule · Prescription medication
Sungwon Adcock Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 300mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Hanmi Pharm. Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.